FOXO1 typically inhibits the expression of epithelial-mesenchymal transition (EMT)-inducing transcription factors and transforming growth factor-beta (TGF-β), leading to a subsequent increase in EMT and HCC cell migration and invasion (46, 47). This evidence concerns the gene FOXO1 and hepatocellular carcinoma.